Literature DB >> 30761759

Structural, biochemical and biophysical characterization of recombinant human fumarate hydratase.

Mariana A Ajalla Aleixo1, Victor L Rangel1, Joane K Rustiguel1, Ricardo A P de Pádua1, Maria Cristina Nonato1.   

Abstract

Fumarate hydratases (FHs, fumarases) catalyze the reversible conversion of fumarate into l-malate. FHs are distributed over all organisms and play important roles in energy production, DNA repair and as tumor suppressors. They are very important targets both in the study of human metabolic disorders and as potential therapeutic targets in neglected tropical diseases and tuberculosis. In this study, human FH (HsFH) was characterized by using enzyme kinetics, differential scanning fluorimetry and X-ray crystallography. For the first time, the contribution of both substrates was analyzed simultaneously in a single kinetics assay allowing to quantify the contribution of the reversible reaction for kinetics. The protein was crystallized in the spacegroup C2221 , with unit-cell parameters a = 125.43, b = 148.01, c = 129.76. The structure was solved by molecular replacement and refined at 1.8 Å resolution. In our study, a HEPES molecule was found to interact with HsFH at the C-terminal domain (Domain 3), previously described as involved in allosteric regulation, through a set of interactions that includes Lys 467. HsFH catalytic efficiency is higher when in the presence of HEPES. Mutations at residue 467 have already been implicated in genetic disorders caused by FH deficiency, suggesting that the HEPES-binding site may be important for enzyme kinetics. This study contributes to the understanding of the HsFH structure and how it correlates with mutation, enzymatic deficiency and pathology.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  enzymatic kinetics; fumarase; protein structure; thermofluor

Mesh:

Substances:

Year:  2019        PMID: 30761759     DOI: 10.1111/febs.14782

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

1.  Protein mass spectrometry reveals lycorine exerting anti-multiple-myeloma effect by acting on VDAC2 and causing mitochondrial abnormalities.

Authors:  Hui Yi; Xiaokai Shen; Haiqin Wang; Saiqun Luo; Wancheng Guo; Peng Chen; Lei Hu; Long Liang; Yanfei Gong; Xiaojuan Xiao; Jing Liu
Journal:  Biotechnol Lett       Date:  2021-01-01       Impact factor: 2.461

2.  Structural and Biochemical Investigations of the [4Fe-4S] Cluster-Containing Fumarate Hydratase from Leishmania major.

Authors:  Patricia R Feliciano; Catherine L Drennan
Journal:  Biochemistry       Date:  2019-11-27       Impact factor: 3.162

3.  A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis.

Authors:  Matthew C Sinton; Jose Meseguer-Ripolles; Baltasar Lucendo-Villarin; Sara Wernig-Zorc; John P Thomson; Roderick N Carter; Marcus J Lyall; Paul D Walker; Alpesh Thakker; Richard R Meehan; Gareth G Lavery; Nicholas M Morton; Christian Ludwig; Daniel A Tennant; David C Hay; Amanda J Drake
Journal:  iScience       Date:  2020-12-11

4.  Functional Characterization of FH Mutation c.557G>A Underlies Uterine Leiomyomas.

Authors:  Ping Li; Yanru Wu; Huizhi Wu; Qiuhong Xiong; Na Zhao; Guangxin Chen; Changxin Wu; Han Xiao
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

5.  Sericin-mediated improvement of dysmorphic cardiac mitochondria from hypercholesterolaemia is associated with maintaining mitochondrial dynamics, energy production, and mitochondrial structure.

Authors:  Kitiya Rujimongkon; Sumate Ampawong; Duangnate Isarangkul; Onrapak Reamtong; Pornanong Aramwit
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

6.  The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry.

Authors:  Xujun Liu; Wenzhe Si; Lin He; Jianguo Yang; Yani Peng; Jie Ren; Xiaoping Liu; Tong Jin; Huajing Yu; Zihan Zhang; Xiao Cheng; Wenting Zhang; Lu Xia; Yunchao Huang; Yue Wang; Shumeng Liu; Lin Shan; Yu Zhang; Xiaohan Yang; Haixia Li; Jing Liang; Luyang Sun; Yongfeng Shang
Journal:  Signal Transduct Target Ther       Date:  2021-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.